Mutagenesis Advance Access originally published online on March 22, 2005
Mutagenesis 2005 20(2):81-92; doi:10.1093/mutage/gei017
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
COMMENTARY |
The emperor wears no clothes in the field of carcinogen risk assessment: ignored concepts in cancer risk assessment
National Food Safety Toxicology Center, Department of Pediatrics and Human Development, Michigan State University, East Lansing, MI 48824, USA
The following is a position paper challenging the paradigm that ‘carcinogen = mutagen’, and that the current rodent bioassay to predict risks to human cancers is relevant and useful. Specifically, we review current observations concerning carcinogenesis that might lead to another approach for assessing the identification of human carcinogenic hazards and the risk assessment that chemicals might pose. We give a brief review of the multistage and multimechanism process of cancer in a tissue that involves not only genotoxic but also epigenetic events, and the importance of stem and progenitor cells in the development of cancer. We focus on the often ignored ‘epigenetic’ effects of carcinogens and the role of cell communication systems in epigenetically altering gene expression that leads to an imbalance of cell proliferation, differentiation and apoptosis in a tissue that can contribute to the cancer process. To draw attention to the fact that the current paradigm and policy to test toxic chemicals is often misleading and incorrect, we discuss how oxidative stress, in spite of the DNA damaging data, most probably contributes to cancer at the epigenetic level. Additionally, we briefly review how this mutagenic concept has greatly diverted attention away from doing research on the lower molecular weight, non-genotoxic, polycyclic aromatic hydrocarbons (PAHs), and how these low molecular weight PAHs are etiologically more relevant to the disease potential of environmental mixtures such as cigarette smoke.
* To whom correspondence should be addressed. Tel: +1 517 432 3100, Ext. 188; Fax: +1 517 432 6340; Email: james.trosko{at}ht.msu.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. E. Trosko REVIEW PAPER: Cancer Stem Cells and Cancer Nonstem Cells: From Adult Stem Cells or from Reprogramming of Differentiated Somatic Cells Vet. Pathol., March 1, 2009; 46(2): 176 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Simeckova, J. Vondracek, Z. Andrysik, J. Zatloukalova, P. Krcmar, A. Kozubik, and M. Machala The 2,2',4,4',5,5'-Hexachlorobiphenyl-Enhanced Degradation of Connexin 43 Involves Both Proteasomal and Lysosomal Activities Toxicol. Sci., January 1, 2009; 107(1): 9 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. Martin Epigenomics and disease, 10th anniversary winter meeting of the UK Molecular Epidemiology Group (MEG), The Royal Statistical Society, London, UK, 8th December 2006 Mutagenesis, November 1, 2007; 22(6): 425 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.J. Tweats, A.D. Scott, C. Westmoreland, and P.L. Carmichael Determination of genetic toxicity and potential carcinogenicity in vitro--challenges post the Seventh Amendment to the European Cosmetics Directive Mutagenesis, January 1, 2007; 22(1): 5 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. P. Pogribny, V. P. Tryndyak, L. Muskhelishvili, I. Rusyn, and S. A. Ross Methyl Deficiency, Alterations in Global Histone Modifications, and Carcinogenesis J. Nutr., January 1, 2007; 137(1): 216S - 222S. [Abstract] [Full Text] [PDF]
|
|